Description
Embracing cross border opportunities in biopharmaceuticals to benefit from possible collaborations in R&D, manufacturing and outsourcing
The global biopharmaceutical industry is currently experiencing exponential growth with substantial opportunities to establish relationships and presence in established and emerging markets. Major global drug companies are increasingly turning to biotechnology for new products to fuel growth with many turning to Asia to tap the abundant outsourcing and collaboration opportunities in drug development and manufacturing. With a continued string of investments in biopharmaceuticals, it is vital for organisations to identify new trends and analyse future prospects in order to form alliances and capitalise on strategic partnerships to gain an edge in this highly competitive market.
